✦ LIBER ✦

149 THREE SCHEDULES OF ADJUVANT INTRAVESICAL EPIRUBICIN IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER: A COMPARATIVE STUDY

✍ Scribed by K. Hendricksen; L.A. Kiemeney; C. Caris; R. Janzing; W. Witjes; J.A. Witjes

Book ID: 119617481
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 316 KB
Volume: 6
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(07)60148-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Three Schedules of Intrave

Comparison of Three Schedules of Intravesical Epirubicin in Patients with Non–Muscle-Invasive Bladder Cancer

✍ Kees Hendricksen; Wim P.J. Witjes; Jan G. Idema; Jan J.M. Kums; Oncko B. van Vie 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 214 KB

1669 INTRAVESICAL ADJUVANT ELECTROMOTIVE

1669 INTRAVESICAL ADJUVANT ELECTROMOTIVE MITOMYCIN-C IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER A RANDOMIZED CONTROLLED TRIAL

✍ Di Stasi, Savino Mauro; Verri, Cristian; Liberati, Emanuele; Micali, Francesco; 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

A RANDOMISED STUDY EVALUATING MAINTENANC

A RANDOMISED STUDY EVALUATING MAINTENANCE SCHEDULE IN EARLY ADJUVANT CHEMOTHERAPY FOR INTERMEDIATE RISK NON-MUSCLE-INVASIVE BLADDER CANCER

✍ V. Serretta; V. Altieri; G. Morgia; P. Annese; G. Carrieri; A. Zito; A. Di Lallo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

755 Prediction of recurrence probabiliti

755 Prediction of recurrence probabilities after intravesical treatment in patients with non-muscle-invasive bladder cancer

✍ Lammers, R.J.M.; Hendriks, J.C.M.; Palou, J.; Witjes, W.P.J.; Witjes, J.A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 126 KB

PHASE 1 STUDY OF MULTI-DOSE ADMINISTRATI

PHASE 1 STUDY OF MULTI-DOSE ADMINISTRATION OF INTRAVESICAL CG0070 IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)

✍ McKiernan, James M; Lamm, Donald L; Meng, Maxwell V; Nemunaitis, John J; Arsenea 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 130 KB

700 Results of a phase-1 dose escalation

700 Results of a phase-1 dose escalation study of intravesical TMX-101 in patients with non-muscle invasive bladder cancer

✍ Falke, J.; Lammers, J.M.; Arentsen, H.C.; Ravic, M.; Pozzi, R.; Cornel, E.B.; Ve 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 71 KB